Literature DB >> 23279506

Validation of a model to develop a symptom index for benign prostatic hyperplasia in dogs.

D Zambelli1, M Cunto, F Gentilini.   

Abstract

Benign prostatic hyperplasia (BPH) is a spontaneous and age-related condition in humans and intact male dogs. A symptom index for BPH in men was created by the American Urological Association. In this study, it has been developed and statistically validated as a model to assign an objective score to canine BPH severity based on clinical signs observed and/or subjectively reported to the veterinarian by dog owners. The medical records of the Animal Reproduction Unit of University of Bologna (Italy) were used to select dogs with a clinical diagnosis of BPH. A data set was built up, and the animals were included in the statistical analysis as dependent variables. A score of 1-3 was assigned to the disease severity of each case based on signs annotated, graded using a scale ranging from 1 to 4. Signs of BHP were entered as predictors while disease severity as dependent variable to generate the predictive model. The model was finally used to re-classify each case of the data set, and the percentage of corrected predictions calculated. Overall, 373 subjects were entered in the model. Between them, 243, 107 and 23 animals have been represented based on medical records with a BPH severity score of 1, 2 and 3, respectively. The model correctly predicted the response variable in 97.3% of the cases. In this study, a BPH symptom index was created for the first time in dogs, which may be useful to standardize BPH severity with an objective score and to evaluate the necessity, the kind and the effectiveness of treatment.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Year:  2012        PMID: 23279506     DOI: 10.1111/rda.12084

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  5 in total

1.  Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.

Authors:  Radmehr Shafiee; Alireza Shariat; Soheil Khalili; Hamed Zamankhan Malayeri; Aram Mokarizadeh; Ali Anissian; Mohammad Reza Hafezi Ahmadi; Ehsan Hosseini; Mostafa Naderafif; Siamak Mohsenzadeh; Mohammad Hosein Rasoulian; Reza Rezapour; Maryam Pourzaer
Journal:  Tumour Biol       Date:  2014-11-25

2.  A retrospective review of canine benign prostatic hyperplasia with and without prostatitis.

Authors:  Hannah Ruetten; Marlyse Wehber; Mary Murphy; Clara Cole; Simran Sandhu; Steven Oakes; Dale Bjorling; Kenneth Waller; Katrina Viviano; Chad Vezina
Journal:  Clin Theriogenology       Date:  2021-12

3.  Alteration of the cholinergic system and motor deficits in cholinergic neuron-specific Dyt1 knockout mice.

Authors:  Yuning Liu; Hong Xing; Wanhui Sheng; Kyle N Singh; Alexandra G Korkmaz; Caroline Comeau; Maisha Anika; Alexis Ernst; Fumiaki Yokoi; David E Vaillancourt; Charles J Frazier; Yuqing Li
Journal:  Neurobiol Dis       Date:  2021-03-20       Impact factor: 7.046

4.  An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction.

Authors:  Hannah Ruetten; Clara Cole; Marlyse Wehber; Kyle A Wegner; Nicholas M Girardi; Nelson T Peterson; Brandon R Scharpf; Michael F Romero; Michael W Wood; Sara A Colopy; Dale E Bjorling; Chad M Vezina
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

Review 5.  Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models.

Authors:  Fei Sun; Claudia Báez-Díaz; Francisco Miguel Sánchez-Margallo
Journal:  Transl Androl Urol       Date:  2017-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.